Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...

Pathophysiology of Cardiac Performance

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...

Introduction Cardiac Emergencies

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Causes of Preanalytical Interferences on Laboratory Immunoassays - A Critical Review.

EJIFCC·2020

Same author

Sample management for clinical biochemistry assays: Are serum and plasma interchangeable specimens?

Critical reviews in clinical laboratory sciences·2018

Same author

Robotic assisted radical prostatectomy accelerates postoperative stress recovery: Final results of a contemporary prospective study assessing pathophysiology of cortisol peri-operative kinetics in prostate cancer surgery.

Asian journal of urology·2017

Same author

Preanalytical Nonconformity Management Regarding Primary Tube Mixing in Brazil.

Journal of medical biochemistry·2017

Same author

Patient posture for blood collection by venipuncture: recall for standardization after 28 years.

Revista brasileira de hematologia e hemoterapia·2017

Same author

Lipid profile, changes in laboratory prescriptions are necessary.

Journal of clinical lipidology·2017

Search research articles

Related Experiment Video

Updated: Jul 5, 2026

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits

Published on: February 28, 2025

Sudden cardiac death: prevalence, pathogenesis, and prevention.

Martina Montagnana¹, Giuseppe Lippi, Massimo Franchini

¹Sezione di Chimica e Microscopia Clinica, Dipartimento di Scienze Morfologico-Biomediche, Universita degli Studi di Verona, Italy. martina.montagnana@med.lu.se

Annals of Medicine

|May 20, 2008

Summary

Sudden cardiac death (SCD) is a global health issue. Understanding its complex causes, from genetic factors to environmental triggers, is key to developing personalized medicine for prevention and treatment.

More Related Videos

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

Related Experiment Videos

Last Updated: Jul 5, 2026

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits

Published on: February 28, 2025

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

Area of Science:

Cardiology
Genetics
Clinical Medicine

Background:

Sudden cardiac death (SCD) is a significant global health concern, defined as unexpected death from a cardiac cause.
Its complex pathogenesis involves the interaction of triggering factors with underlying genetic or acquired heart conditions.
Lethal tachyarrhythmias or bradycardia are the typical outcomes of this interaction.

Purpose of the Study:

To provide a concise overview of sudden cardiac death (SCD).
To cover prevalence, pathogenesis, clinical presentation, and diagnostic strategies for SCD.
To highlight the importance of clinical and diagnostic approaches for personalized medicine in SCD.

Main Methods:

Literature review and synthesis of current knowledge on SCD.
Analysis of genetic and environmental factors contributing to SCD.
Discussion of clinical and diagnostic methodologies for SCD.

Main Results:

SCD pathogenesis is multifactorial, involving genetic and environmental influences.
Early identification of risk factors through clinical and diagnostic means is crucial.
Personalized medicine frameworks can be developed for SCD management.

Conclusions:

A comprehensive understanding of SCD's multifaceted nature is essential.
Reliable diagnostic approaches are vital for identifying at-risk individuals.
Personalized medicine holds promise for improving SCD prevention and treatment outcomes.